Home › Funds › Seven Fleet Capital Management LP › EDIT
Seven Fleet Capital Management LP position in EDIT
EDITAS MEDICINE INC · Health Care
Seven Fleet Capital Management LP reported holding 1,915,871 shares of EDIT (EDITAS MEDICINE INC) in its Q3 2026 13F filing — a position valued at US$2.9M, representing 0.58% of its reported portfolio and ranking #34 among its reported holdings. Seven Fleet Capital Management LP has disclosed EDIT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Seven Fleet Capital Management LP's EDIT position evolved
Seven Fleet Capital Management LP first disclosed a stake in EDIT in Q2 2026 at 1,330,500 shares (US$4.3M). Across 2 filings, Seven Fleet Capital Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,915,871 shares valued at US$2.9M — an increase of 585,371 shares quarter over quarter.. Notable position changes include a 44% increase in Q3 2026 (shares fell 27% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 1.33M | $4.31M | New |
| Q3 2026 | 1.92M | $2.94M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EDIT and 13F data
EDIT (EDITAS MEDICINE INC) is a Health Care company. 36 other funds we track also report a position in EDIT — the largest reported positions include TCG Crossover Management, LLC (US$28.6M), ADAR1 Capital Management, LLC (US$22.8M), Commodore Capital LP (US$22.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EDIT
- TCG Crossover Management, LLC 11.11M sh · $28.56M · Q3 2026
- ADAR1 Capital Management, LLC 8.89M sh · $22.84M · Q3 2026
- Commodore Capital LP 8.89M sh · $22.84M · Q3 2026
- Paradigm Biocapital Advisors LP 7.58M sh · $19.47M · Q3 2026
- Opaleye Management Inc. 3.86M sh · $12.51M · Q2 2026
- Vivo Capital, LLC 3.56M sh · $9.14M · Q3 2026
- GordonMD Global Investments LP 3.13M sh · $8.04M · Q3 2026
- Logos Global Management LP 2.22M sh · $5.71M · Q3 2026
- HighVista Strategies LLC 1.11M sh · $2.85M · Q3 2026
More on Seven Fleet Capital Management LP
FAQ
How long has Seven Fleet Capital Management LP held EDIT?
Seven Fleet Capital Management LP has disclosed EDIT holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Seven Fleet Capital Management LP's current position in EDIT?
As of Q3 2026, Seven Fleet Capital Management LP holds 1.92M shares of EDIT (EDITAS MEDICINE INC), valued at $2.94M, representing 0.58% of its reported portfolio and ranking #34.
Has Seven Fleet Capital Management LP been buying or selling EDIT?
In the latest 13F filing (Q3 2026), Seven Fleet Capital Management LP increased its position in EDIT.
Which other funds hold EDIT?
Other major institutional holders of EDIT include TCG Crossover Management, LLC, ADAR1 Capital Management, LLC, Commodore Capital LP, among 36 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.